Brain Tumor Resource Lab

Best characterized models of the Brain Tumor Resource Lab.png

The Brain Tumor Resource Lab strives to generate and distribute patient-derived xenograft models and cell lines. Our focus is on pediatric brain tumors.

The figure at right depicts the best-characterized models for comparison. Click on it for a larger version.

Please note that the tissue culture lines should not be implanted into mice and patient-derived xenograft cell lines should not be used for tissue culture.

These resources are for academic use only. Please contact us if you are interested in other uses.

Similar to ATCC, the only way to obtain these lines is to place an order through this site. This ensures that we can contact you if important information needs to be conveyed, that you understand that the lines cannot be shared, that a material transfer agreement is in place and that we can track how these lines are used to benefit science and medicine.

We gratefully acknowledge funding from the National Institutes of Health, Seattle Run of Hope, the German Cancer Consortium (DKTK), and the German Cancer Research Center (DKFZ), Heidelberg, Germany.

Order Cell Lines Contact Us

Resources


BTRL Cell Line Information

Note: Please check the order sheet to see the availability for the cell lines below. Some cell lines might not be immediately available and will be processed on an as-available basis.

Medulloblastoma Lines

Med-113FH

Med-113FH cellsTumor Classification

Medulloblastoma, Group 3: 17p, 9q, PTCH1

Available As

Mouse Xenograft

See Details

Med-114FH

Med-114FH cellsTumor Classification

Medulloblastoma, Group 3: 17p

Available As

Mouse Xenograft
mCherry/luciferase Mouse Xenograft
Tissue Culture Line

See Details

Med-1512FH

Med-1512FH cellsTumor Classification

Medulloblastoma, Group 4: MYCN

Available As

Mouse Xenograft

See Details

Med-1712FH

Med-1712FH cellsTumor Classification

Medulloblastoma, SHH: 9q, PTCH1

Available As

Mouse Xenograft

See Details

Med-1911FH

Tumor Classification

Medulloblastoma, Group 3: 17p

Available As

Mouse Xenograft

See Details

Med-210FH

Med-210FH cellsTumor Classification

Medulloblastoma, Group 3: 17q, 9q

Available As

Mouse Xenograft

See Details

Med-2112FH

Med-2112FH cellsTumor Classification

Medulloblastoma, Group 3: MYC, 17p, 17q, 9p

Available As

Mouse Xenograft
mCherry/luciferase Mouse Xenograft
Tissue culture line available

See Details

Med-211FH

Med-211FH cellsTumor Classification

Medulloblastoma, Group 3: 17p

Available As

Mouse Xenograft

See Details

Med-2312FH

Med-2312FH cellsTumor Classification

Medulloblastoma, Group 4: 17p, 17q, 9q

Available As

Mouse Xenograft

See Details

Med-314FH

Med-314FH cellsTumor Classification

Medulloblastoma, SHH: TP53, MYCN, GLI2, 17p, 17q, 9q

Available As

Mouse Xenograft
mCherry/luciferase Mouse Xenograft

See Details

Med-411FH

Med-411FH cellsTumor Classification

Medulloblastoma, Group 3: MYC, 17q, 17p

Available As

Mouse Xenograft
mCherry/luciferase Mouse Xenograft
Tissue culture line available

See Details

Med-610FH

Med-610FH cellsTumor Classification

Medulloblastoma, Group 4: 17q, PRDM6

Available As

Mouse Xenograft

See Details

Med-615FH

Has not yet been characterized.

Med-813FH

Med-813FH cellsTumor Classification

Medulloblastoma, SHH: TP53, MYCN, GLI2, 17p, 17q, 9q

Available As

Mouse Xenograft

See Details

Med-913FH

Med-913FH cellsTumor Classification

Medulloblastoma, WNT: CTNNB1

Available As

Mouse Xenograft

See Details

PBT-07FH

PBT-07FH cellsTumor Classification

Medulloblastoma, Group 3: KBTBD4, 17p, 17q, 9q

Available As

Mouse Xenograft

See Details

Ependymoma Lines

EPD-210FH

EPD-210FH cellsTumor Classification

Ependymoma, PFA: 1q

Available As

Mouse Xenograft

See Details

Tissue Culture Line

See Details

EPD-313FH

Tumor Classification

Ependymoma

Both Tissue Culture and PDX cell lines available

EPD-410FH

EPD-410FH cellsTumor Classification

Ependymoma

Available As

PDX Cell Line

EPD-613FH

EPD-613FH cellsTumor Classification

Ependymoma, RELA fusion: CDKN2A/B, RELA

Available As

Mouse Xenograft

See Details

EPD-710FH

Tumor Classification

Ependymoma, PFA: 1q

Available As

Mouse Xenograft

See Details

Pineoblastoma Cell Lines

PBT-08FH

PBT-08FH cellsTumor Classification

Pineoblastoma

Available As

Mouse Xenograft

See Details

High Grade Glioma Lines

PBT-01FH

PBT-01FH cellsTumor Classification

High Grade Glioma, K27: EGFR, H3FA/HIST1H3B

Available As

Mouse Xenograft

See Details

PBT-02FH

PBT-02FH cellsTumor Classification

High Grade Glioma, pedRTK1: CDK4, FGFR1-4, MDM2

Available As

Mouse Xenograft

See Details

PBT-03FH

Tumor Classification

High Grade Glioma, K27: ATRX, H3FA/HIST1H3B, SETD1A, TP53

Available As

Mouse Xenograft

See Details

PBT-04FH

PBT-04FH cellsTumor Classification

High Grade Glioma, MYCN: ID2, MYCN

Available As

Mouse Xenograft

See Details

PBT-05FH

PBT-05FH cellsTumor Classification

High Grade Glioma, MYCN: ID2, MYCN, EGFR, PIK3R1, MGMT methylation

Available As

Mouse Xenograft

See Details

Tissue Culture

See Details

PBT-06FH

PBT-06FH cellsTumor Classification

High Grade Glioma, PedRTK1: CDK4, PDGFRA, TERT, TP53

Available As

Mouse Xenograft

See Details

GBM-311FH

GBM-311FH cellsTumor Classification

High Grade Glioma, pedRTK1: ATRX, EGFR, FGFR1-4, MGMT metylation, MSH2, hypermutator

Available As

Mouse Xenograft

See Details

GBM-511FHTC

Tumor Classification

High Grade Glioma, PedTRK1: CDKN2A/B

Available As

Tissue Culture

See Details

GBM-611FH

GBM-611FH cellsTumor Classification

High Grade Glioma, pedRTK1: ATRX, EGFR, FGFR1-4, MSH2, hypermutator

Available As

Mouse Xenograft

See Details

GBM-711FH

Tumor Classification

High Grade Glioma

Available As

Mouse Xenograft

Astro-111FHTC

Has not been characterized, TC line only

Tumor Classification

Astrocytoma

GBM-109FHTC

Has not been characterized, TC line only

Tumor Classification

High Grade Glioma

GBM-110FHTC

Tumor Classification

High Grade Glioma, pedRTK2: BRAF, CDKN2A/B

See Details

PBT-22FHTC

Tumor Classification

DMG H3.3K27M

See Details

PBT-24FHTC

Tumor Classification

DMG H3wt: hypermutator

See Details

PBT-27FHTC

Tumor Classification

DMG H3.1 K27M

See Details

PBT-29FHTC

Tumor Classification

DMG H3.3K27M

See Details

Atypical Teratoid Rhabdoid Tumor Cell Lines

ATRT-310FH/ATRT-333FH

ATRT-310FH/ATRT-333FH cellsTumor Classification

Atypical Teratoid Rhabdoid, SHH: SMARCB1

Available As

Mouse Xenograft

See Details

Tissue Culture Line

See Details

ATRT-311FHTC

Tumor Classification

Atypical Teratoid Rhabdoid, SHH: SMARCB1

Available As

Mouse Xenograft

See Details

ATRT-312FH

ATRT-312FH cellsTumor Classification

Atypical Teratoid Rhabdoid, MYC: SMARCB1

Available As

Mouse Xenograft

See Details

Terms and Conditions

In consideration for and as a condition to the receipt of cell lines from the Brain Tumor Resource Laboratory of Seattle Children’s Research Institute ("SCRI"). the undersigned investigator (“Recipient Scientist”) and institution (“Institution”) agree, represent and warrant as follows:

  1. Institution is a non-profit, educational or research organization.
  2. The Material provided to Recipient Scientist is to be used solely for research purposes at Institution and only under the direction of Recipient Scientist. The Material will not be used in human subjects or in clinical trials involving human subjects. Recipient Scientist and Institution agree not to sell, use or transfer for commercial purposes the Material or their products or to transfer the material to anyone who does not work under the direct supervision of Recipient Scientist at Institution.
  3. Recipient Scientist may publish the results of his or her research using the Material in scientific journals. Recipient Scientist agrees to acknowledge SCRI as the provider of the Material.
  4. Recipient Scientist and Institution understand and agree that Material delivered pursuant to this Agreement may have hazardous properties. Recipient Scientist and Institution agree to take appropriate safety measures concerning the use, storage, disposal of the Material. SCRI makes no representation and extends no warranties of any kind either express or implied including, without limitation any warranties or merchantability or fitness for a particular purpose or that the use of the Material will not infringe any patent, copyright, trademark or other proprietary right.
  5. Except to the extent prohibited by law, Recipient Scientist and Institution assume all liability for damages or loss arising from the use, storage or disposal of the Material. Except to the extent prohibited by law, Recipient Scientist and Institution agree to indemnify, defend and hold harmless SCRI and its employees, officers, trustees and agents from and against any and all loss, damage or liability arising from the use, storage or disposal of the Material by Recipient Scientist, Institution or their employees or agents.
  6. Recipient Scientist and Institution agree to use the Material in compliance with all applicable statutes and regulations.

Contact Us

Physical Address

Norcliffe Foundation Center for Integrative Brain Research
1900 Ninth Ave.
Seattle, WA 98101